LPA and glioma: Moreover, Schleicher et al. reported that BrP-LPA, a novel dual-function pan-LPA antagonist/ATX inhibitor, enhances radiation-induced endothelial cell death, disrupts endothelial cell biological function, and reduces glioma cell viability and migration [124].